Fig. 6.
Fig. 6. The BM-HPCs engraft after serial transplantation into tertiary recipients. / (A) Fraction of donor-derived erythrocytes in peripheral blood at different time points of 7 individual tertiary stem cell–deficient B6W recipients. All mice received 2 × 106 BM cells from the secondary B6W recipient. The secondary recipient used was killed 6 months after transplantation. The secondary recipient received BM cells from a primary recipient killed 9 months after transplantation. (B) May-Grünwald Giemsa staining of nucleated cells from BM isolated from a tertiary recipient killed 4 months after transplantation. Original magnification B, × 40. (C) Gpi assay of the nucleated cells in the BM and of erythrocytes in peripheral blood (PB) of the same individual analyzed in panel B.

The BM-HPCs engraft after serial transplantation into tertiary recipients.

(A) Fraction of donor-derived erythrocytes in peripheral blood at different time points of 7 individual tertiary stem cell–deficient B6W recipients. All mice received 2 × 106 BM cells from the secondary B6W recipient. The secondary recipient used was killed 6 months after transplantation. The secondary recipient received BM cells from a primary recipient killed 9 months after transplantation. (B) May-Grünwald Giemsa staining of nucleated cells from BM isolated from a tertiary recipient killed 4 months after transplantation. Original magnification B, × 40. (C) Gpi assay of the nucleated cells in the BM and of erythrocytes in peripheral blood (PB) of the same individual analyzed in panel B.

Close Modal

or Create an Account

Close Modal
Close Modal